About the Intraocular Melanoma Session
Intraocular melanoma is a rare form of cancer that develops in the eye's melanocytes, the cells responsible for producing melanin. Although uncommon, it is the most common primary intraocular malignancy in adults. Research into intraocular melanoma focuses on understanding its genetic basis, risk factors, and treatment options. Advances in molecular biology have identified genetic mutations associated with the disease, aiding in personalized treatment strategies. Current research efforts also explore novel therapies, including targeted drugs and immunotherapy, to improve outcomes for patients. Early detection through regular eye exams remains crucial for effective management, highlighting the importance of ongoing research in combating this challenging disease.
Topics Covered in Intraocular Melanoma
Choroidal Melanoma
Iris & Ciliary Tumors
Gene Expression Profiling
Plaque Brachytherapy
T-Cell Engager Therapy
Hepatic Metastases
Related Scientific Sessions at CIOC 2027
Why Attend the Intraocular Melanoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Intraocular Melanoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Intraocular Melanoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Intraocular Melanoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Intraocular Melanoma Conference 2027 — FAQs
What is the Intraocular Melanoma track at CIOC 2027?
The Intraocular Melanoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Intraocular Melanoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Intraocular Melanoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Intraocular Melanoma are all welcome — whether presenting or attending.
Can I present my research in the Intraocular Melanoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Intraocular Melanoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Intraocular Melanoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.